BIOKIT S.A. – Trademark Portfolio

Entity Type: 03

BIOKIT S.A. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BIOKIT and MONOGEN. The owner is based in BARCELONA.

CALLE CORCEGA 603-605

BARCELONA , ES

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BIOKIT S.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does BIOKIT S.A. have?

BIOKIT S.A. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 4 cancelled.

What trademark classes does BIOKIT S.A. file in?

BIOKIT S.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BIOKIT S.A.'s most well-known trademarks?

BIOKIT S.A.'s registered trademark portfolio includes well-known marks such as BIOKIT and MONOGEN. These are among 2 currently registered trademarks in the portfolio.

What is BIOKIT S.A.'s trademark registration success rate?

BIOKIT S.A. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.